A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84

Lyne Gagnon1, Martin Leduc1, Jean-Francois Thibodeau2

  • 1Prometic BioSciences Inc., Laval, Québec, Canada.

Insights

GPR40 and GPR84 receptors are involved in organ fibrosis. The drug PBI-4050 targets these receptors, showing significant antifibrotic effects across multiple organs, suggesting potential for treating fibrosis-related diseases.

Area of Science:

  • Molecular biology
  • Pharmacology
  • Pathophysiology

Background:

  • Organ fibrosis is a significant clinical challenge requiring novel therapeutic strategies.
  • G protein-coupled receptors GPR40 and GPR84, linked to metabolic and inflammatory conditions, have not been previously associated with fibrosis.
  • Understanding the role of GPR40 and GPR84 in fibrotic diseases is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of GPR40 and GPR84 in organ fibrosis.
  • To evaluate the antifibrotic potential of PBI-4050, a compound targeting GPR40 and GPR84.

Main Methods:

  • Utilized Gpr40- and Gpr84-knockout mouse models to study kidney fibrosis.
  • Employed various kidney injury models: unilateral ureteral obstruction, chronic ischemic injury, and adenine-induced chronic kidney disease.
  • Assessed the antifibrotic effects of PBI-4050 in multiple organ fibrosis models (kidney, liver, heart, lung, pancreas, skin).

Main Results:

  • GPR40 demonstrated a protective role, while GPR84 exhibited a deleterious effect in kidney fibrosis models.
  • PBI-4050 significantly attenuated fibrosis across kidney, liver, heart, lung, pancreas, and skin fibrosis models.
  • The drug's efficacy was linked to its interaction with both GPR40 and GPR84.

Conclusions:

  • GPR40 and GPR84 are identified as key players in fibrosis pathways, with opposing roles.
  • PBI-4050 exhibits broad-spectrum antifibrotic activity, highlighting its therapeutic potential.
  • GPR40 and GPR84 represent promising molecular targets for managing inflammatory and fibrosis-related diseases.

Related Concept Videos

Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.3K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.5K
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.4K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K
Respiratory Regulation of Acid-Base Balance01:18

Respiratory Regulation of Acid-Base Balance

Respiratory compensation is a vital physiological process that stabilizes blood plasma pH by regulating the partial pressure of carbon dioxide (PCO2), a key determinant of pH levels. Most carbon dioxide in the blood dissolves and converts into carbonic acid (H2CO3). It dissociates into hydrogen ions (H+) and bicarbonate ions (HCO3⁻). There is also an inverse relationship between PCO2​​ and pH.
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
1.8K
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
1.9K